The clinical translation of eicosanoids and other oxylipins, although challenging, should be actively pursued

[1]  W. Griffiths,et al.  The Biosynthesis of Enzymatically Oxidized Lipids , 2020, Frontiers in Endocrinology.

[2]  J. Bertrand-Michel,et al.  Stability of oxylipins during plasma generation and long-term storage. , 2020, Talanta.

[3]  Mélanie Pétéra,et al.  Harmonized procedures lead to comparable quantification of total oxylipins across laboratories , 2020, Journal of Lipid Research.

[4]  P. Howarth,et al.  Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study , 2020, American journal of respiratory and critical care medicine.

[5]  Yen-Wen Wu,et al.  Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease , 2020, Scientific Reports.

[6]  D. Gómez-Cabrero,et al.  Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis. , 2020, Journal of hepatology.

[7]  V. Salomaa,et al.  Eicosanoid Inflammatory Mediators Are Robustly Associated With Blood Pressure in the General Population , 2020, Journal of the American Heart Association.

[8]  H. Yin,et al.  An update on lipid oxidation and inflammation in cardiovascular diseases. , 2019, Free radical biology & medicine.

[9]  J. Newman,et al.  MS-based targeted metabolomics of eicosanoids and other oxylipins: Analytical and inter-individual variabilities. , 2019, Free radical biology & medicine.

[10]  H. Yin,et al.  Endogenous cholesterol ester hydroperoxides modulate cholesterol levels and inhibit cholesterol uptake in hepatocytes and macrophages , 2018, Redox biology.

[11]  C. Glass,et al.  Oxidized Phospholipids are Proinflammatory and Proatherogenic in Hypercholesterolemic Mice , 2018, Nature.

[12]  M. Giera,et al.  Isoprostanes, neuroprostanes and phytoprostanes: An overview of 25years of research in chemistry and biology. , 2017, Progress in lipid research.

[13]  R. Murphy,et al.  Directing eicosanoid esterification into phospholipids1 , 2017, Journal of Lipid Research.

[14]  V. Salomaa,et al.  Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Edward A. Dennis,et al.  Eicosanoid storm in infection and inflammation , 2015, Nature Reviews Immunology.

[16]  Rohit Loomba,et al.  Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis1 , 2015, Journal of Lipid Research.

[17]  Yuji Takahashi,et al.  Identification of molecular species of cholesteryl ester hydroperoxides in very low-density and intermediate-density lipoproteins , 2014, Annals of clinical biochemistry.

[18]  E. Mahmud,et al.  Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans. , 2014, Journal of the American College of Cardiology.

[19]  J. Newman,et al.  Impact of circulating esterified eicosanoids and other oxylipins on endothelial function , 2009, Current atherosclerosis reports.

[20]  P. Christmas,et al.  The organization and consequences of eicosanoid signaling. , 2003, The Journal of clinical investigation.

[21]  R. Dean,et al.  Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. , 2002, The American journal of pathology.

[22]  J. Morrow,et al.  Isoprostanes , 1994 .